Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001792612-23-000001
Filing Date
2023-06-16
Accepted
2023-06-16 13:41:42
Documents
1
Effectiveness Date
2023-06-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7873
  Complete submission text file 0001792612-23-000001.txt   8921
Mailing Address 662 ENCINITAS BLVD., SUITE 248 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., SUITE 248 ENCINITAS CA 92024 (310) 502-0770
Avenzoar Pharmaceuticals, Inc. (Filer) CIK: 0001792612 (see all company filings)

EIN.: 475352251 | State of Incorp.: CA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-484484 | Film No.: 231020233